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Abstract 23 
The anti-inflammatory capacity of supercritical CO2 extracts (S1 and S2) obtained from 24 
sage (Salvia officinalis) was evaluated using THP-1 human macrophages activated with 25 
human ox-LDL, a specific in vitro model to determine the anti-inflammatory effect of 26 
the extracts in an atherosclerotic environment. The expression of pro-inflammatory 27 
cytokines, with an important role in the atherogenic process, such as TNF-α, IL-1β and 28 
IL-6, in presence of different extracts concentrations was evaluated. Results showed that 29 
30 μg/mL of both supercritical extracts (S1 and S2) markedly suppressed the ox-LDL 30 
induced production of TNF-α, IL-1β and IL-6, as well as their mRNA expression. Data 31 
showed that S1 presented a higher anti-inflammatory activity than S2.  32 
A characterization by GC-MS of sage extracts identified 16 compounds, mainly 33 
camphor, borneol and 1,8-cineole. These three compounds represented a 62.4% of S1 34 
and a 48.1% of S2. Camphor, borneol and 1,8-cineole presented an important anti-35 
inflammatory activity in the proposed model, with a decrease in the release and gene 36 
expression of TNF-α, IL-1β and IL-6 and an increase in IL-10 expression. These results 37 
explained the higher activity found in S1. 38 
This study suggested that supercritical sage extracts could be used as food ingredients in 39 
the development of anti-inflammatory/anti-atherogenic products. 40 
 41 
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1. Introduction 42 
Atherosclerosis consists of cholesterol deposition in the intima of large and medium 43 
size arteries, accompanied by a chronic inflammatory process (Barter, 2005). A large 44 
body of evidence supports the key role of oxidized low-density lipoproteins (ox-LDL) 45 
in the early inflammatory and more advances stages of the atherosclerosis lesions. Ox-46 
LDL are not recognized by the LDL receptor apo (B/E), but taken up in a non-regulated 47 
manner by the scavenger receptors in monocytes-macrophages and endothelial cells. 48 
This process leads to the accumulation of cholesterol in the macrophages, forming foam 49 
cells, the hallmark of the atherosclerosis lesion (Chouinard et al., 2008). In addition, 50 
these ox-LDLs can induce the expression of adhesion molecules, pro-inflammatory 51 
cytokines (such as TNF-α, Il-1β, and IL-6) and other mediators of inflammation in 52 
macrophages and endothelial cells (Kaperonis et al., 2006).  53 
The functional role of herbs and spices and their constituents is a hot topic in food 54 
related plant research. Herbs and spices, that have been added to foods since ancient 55 
times, mainly to modify or improve their flavor, are nowadays also appreciated for their 56 
biological activities. Extracts and essential oils obtained from several herbs and spices 57 
present different biological activities, including antioxidant, anti-inflammatory, 58 
antitumoral, antiviral and antimicrobial activities (Hamdy et al., 2013; Chan et al., 59 
2011; Tajkarimi et al., 2010; Kaefer and Milmer, 2008; Santoyo et al., 2006a; Santoyo 60 
et al., 2006b;  Shin and Kim, 2002). The genus Salvia is, with about 900 species, one of 61 
the most widespread members of the Lamiaceae family. Although sage is a popular 62 
kitchen herb, it has one of the longest histories of use as medicinal herb. The positive 63 
benefits of Salvia officinalis (common sage) to health are reputed throughout Ancient 64 
Romans times to the Middle Ages; thus this herb has been commonly used for treating 65 
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colds, coughs and bronchial infections. Some studies have reported that species of the 66 
genus Salvia possess specific characteristics which could be used as anti-inflammatory 67 
agents. The in vitro anti-inflammatory activity of several essential oils and solvent 68 
extracts of Salvia species was evaluated using the 5-lipoxygenase assay, indicating that, 69 
in general, essential oils exhibited better anti-inflammatory activity than solvents 70 
extracts (Kamatou et al., 2005). Kamatou et al. (2008) reported the anti-inflammatory 71 
activity of the essential oils of Salvia rapens, Salvia runcinata and Salvia stenophylla 72 
measuring the inhibition of cyclo-oxigenase-1 (COX-1) and COX-2, two key enzymes 73 
in the inflammation process. The results indicated that the three essential oils inhibited 74 
COX-2 enzyme, being Salvia stenophylla the most active. Also Mueller et al., (2010) 75 
indicated that an extract from Salvia officinalis presented anti-inflammatory activity, 76 
since this extracts moderately reduced the secretion of pro-inflammatory cytokines like 77 
IL-6 and TNF-α. In the same way, Wang et al. (2006), reported that an extract from 78 
Salvia miltiorrhiza was able to suppress LPS-induced TNF-α in human peripheral blood 79 
leukocytes and RAW 264.7 macrophage cell line. Using the same inflammation model, 80 
more recently Abu-Darwish et al. (2013) described a reduction in NO production after 81 
the incubation of activated cells with common sage extracts obtained by 82 
hydrodistillation. Besides, Ehrnhöfer-Ressler et al. (2013) indicated the anti-83 
inflammatory activity of a S. officinalis infusion was due to a reduction of IL-6 and IL-8 84 
release in activated human gingival fibroblasts. Using an in vivo model of inflammation, 85 
carrageenan-induced edema in rats, different extracts obtained from Salvia species 86 
showed anti-inflammatory and anti-edematous activity (Çadirci et al., 2012), 87 
specifically hydroalcoholic extracts showed anti-inflammatory activity, correlated with 88 
inhibition of inflammatory mediators release (Alves et al., 2012). 89 
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In recent years, supercritical fluid extraction (SFE) has received increased attention as 90 
an important alternative to the traditional solvent extraction methods, since this 91 
technique provides a high speed and efficiency of extraction, eliminates concentration 92 
steps and avoids the use of organic solvents which are potentially harmful in terms of 93 
environmental impact. SFE is an extraction/fractionation method that exploits the 94 
unique properties of gases above their critical points to extract soluble components from 95 
a raw material. Carbon dioxide is an ideal solvent for the extraction of some classes of 96 
natural substances from food because is non-toxic, non-explosive, readily available and 97 
easy to remove from extracted products. In that way, the quality of supercritical fluid 98 
extracts is higher than those obtained by extraction solvents, water or steam distillation, 99 
since these methods can induce thermal degradation or present the problem of toxic 100 
residual solvent in the products (Diaz-Maroto et al., 2002). In particular, SFE has been 101 
applied to obtain extracts and fractions from S. officinalis essential oils with a higher 102 
terpenoids content than when employing traditional techniques (Aleksovski and Sovová 103 
2007; Gañán and Brignole, 2013; Maksimovic et al., 2013).  Thus, the combination of 104 
SFE and other extraction methods, such as ultrasound-assisted extraction, have been 105 
also used to concentrated sage extracts in diterpenes, the main valuable components 106 
(Glisic et al., 2011).  107 
The aim of this paper was to study the anti-inflammatory capacity of Salvia officinalis 108 
supercritical extracts using THP-1 human macrophages activated with human ox-LDL. 109 
This model of inflammation allowed us to determine the anti-inflammatory effect of the 110 
extracts in an atherosclerotic environment and could be useful to determine the potential 111 
activity of the extracts in the prevention of atherosclerosis. Also, this model has been 112 
used only in few studies, since most of anti-inflammatory studies reported used 113 
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lipopolysaccharide to activate macrophages. Further, this work analysed the chemical 114 
composition of the extracts and intended to establish a relationship between the 115 
extracts’ activity and their composition.  116 
 117 
2. Material and methods 118 
2.1 Samples and chemicals 119 
Sage (Salvia officinalis) sample consisted of dried leaves obtained from a herbalist´s 120 
shop (Murcia, Spain). Cryogenic grinding of the samples was performed under liquid 121 
nitrogen. The size of the particle was determined by passing the ground plant material 122 
through sieves between 1000-500 µm (CISA, Barcelona, Spain). The whole sample was 123 
stored at – 20ºC until use.  124 
1,8-cineole, camphor and borneol standards were purchased from Sigma (Madrid, 125 
Spain). CO2 (N38 quality) was supplied from Air Liquid (Madrid, Spain). 126 
 127 
 2.2 Extraction methods 128 
Supercritical extractions were carried out using a pilot-plant supercritical fluid extractor 129 
(Thar Technology, Pittsburgh, PA, USA, model SF2000), comprising a 2 L cylinder 130 
extraction cell and two different separators (S1 and S2), each of 0.5 L capacity, with 131 
independent control of temperature and pressure. For each experiment, the extraction 132 
vessel was packed with 0.6 kg of the cryogenically milled and sieved plant particles.  133 
Extraction assays were performed at 30 MPa and 313 K, with a CO2 flow rate of 50 134 
g/min. Temperature was set to 313 K in both S1 and S2 separators. In the first separator 135 
(S1) the pressure was maintained at 10 MPa, while in the second separator (S2) the 136 
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pressure was ambient pressure. The cascade decompression system produced two 137 
different extracts with different composition which were collected in separator 1 (S1) 138 
and separator 2 (S2) respectively. According to previous kinetic studies the overall 139 
extraction time was set to be 8 h (García-Risco et al., 2011).  140 
Solid-liquid (S/L) extractions using ethanol and methanol with chloroform were carried 141 
out according to the methods describe by Kamatou et al. (2010, 2005), with several 142 
modifications. For each experiment, 2 g of cryogenically milled and sieved plant 143 
particles were dissolved in 100 mL of 100% of ethanol or 100 mL of 144 
methanol:chloroform (1:1) to obtain two different extracts. In both cases the extraction 145 
time was 4 h at 310 K with shaking (200 rpm) and the process was repeated 3 times. 146 
The extracts were obtained by removing the solvents with a rotary evaporator at 40 °C. 147 
2.3 GC-MS analysis 148 
Characterization of the supercritical sage extracts was carried out by a GC-2010 149 
(Shimadzu, Japan), equipped with a split/splitless injector, electronic pressure control, 150 
AOC-20i auto injector, GCMS-QP2010 Plus mass spectrometer detector, and a GCMS 151 
Solution software. The column used was a ZB-5 (Zebron) capillary column, 30 m x 0.32 152 
mm I.D. and 0.25 µm phase thickness. Helium, 99.996% was used as a carrier gas at a 153 
flow of 1 mL/min. Oven temperature programming was 60 ºC isothermal for 4 min, 154 
increased to 64 ºC at 1 ºC/min, then increased to 106 ºC at 2.5 ºC/min. Oven 155 
temperature was then increased from 106 ºC to 130 ºC at 1 ºC/min, and then to 200 ºC at 156 
5 ºC/min, and then to a final temperature of 250 ºC/min at 8 ºC/min which was kept 157 
constant for 10 min. Sample injections (1 μL) were performed in split mode (1:20). The 158 
inlet pressure of the carrier gas was 57.5 KPa. Injector temperature was of 250 ºC and 159 
MS ion source and interface temperatures were 230 and 280 ºC, respectively. The mass 160 
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spectrometer was used in TIC mode, and samples were scanned from 40 to 500 amu. 161 
Compounds 1,8-cineole, camphor, borneol and linalool were identified by comparison 162 
with standard mass spectra obtained in the same conditions and compared with the mass 163 
spectra from library Wiley 229. The rest of the compounds were identified by 164 
comparison with the mass spectra from Wiley 229 library and by their linear retention 165 
index.   166 
 167 
 2.4 Isolation and oxidation of LDLs 168 
LDLs were isolated from human plasma as described before (Havel et al., 1995). 169 
Oxidation of LDLs was done by incubating LDLs with 5µM CuSO4 for 3h at 37ºC. 170 
Oxidation degree was measured as the amount of thiobarbituric acid reactive substances 171 
(TBARS) produced. 172 
 173 
2.5 Cell culture and treatment 174 
Human THP-1 monocytes (American Type Culture Collection, ATCC) were cultured in 175 
RPMI 1640 culture medium (Gibco, Spain) supplemented with 10% FBS, 100 U/mL 176 
penicillin, 100 mg/mL streptomycin, 2 mM L-glutamine and 0.05 mM β-177 
mercaptoethanol at 37ºC in 95% humidified air containing 5% CO2. Cells were 178 
collected and plated at a density of 5x105 cells/mL in 24 wells plates. Differentiation to 179 
macrophages (THP-1/M cells) was induced by maintaining the THP-1 cells in the 180 
presence of 100 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma, Spain) for 48h. 181 
After differentiation, cells were washed with PBS and incubated with 75 µg/mL ox-182 
LDLs in presence of different concentrations of supercritical extracts, S/L extracts or 183 
pure standards for 24h in a FBS free medium. Then, the supernatant was frozen at -80ºC 184 
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and cells RNA isolated. Indomethacin (4 μg/mL), an anti-inflammatory drug, was used 185 
as a reference. 186 
 187 
2.6 Cytotoxicity assays 188 
The cytotoxic effect of the extracts and pure standards on THP-1/M cells was tested 189 
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay 190 
(Sigma, Spain), according to a publish method (Mosmann, 1983). THP-1/M cells in 24-191 
multiwell plates were incubated with RPMI containing different concentrations of the 192 
extracts for 24h at 37ºC. Cells were then washed with PBS and 0.5 mg/ml of MTT were 193 
added to each well and incubated 4h at 37ºC. Supernatants were discarded and formazan 194 
crystals dissolved in an extraction solution (10% sodium dodecyl sulphate in a mixture 195 
of dimethyl formamide and water 1:1 v/v, adjusted to pH 4.7 with acetic acid) overnight 196 
at 37ºC. Formazan quantification was performed by measuring the optical density at 197 
570 nm using a multiscanner autoreader (Sunrise, Tecan) with the extraction solution as 198 
a blank. The data were plotted as dose-response curves, from which the concentration 199 
required to reduce 50% the number of viable THP-1/M (CC50) after 24 h of incubation 200 
with the different extracts were obtained. 201 
 202 
2.7 Quantification of cytokines by ELISA 203 
The release of IL-1β, IL-10, IL-6 and TNF-α was measured in the supernatants of THP-204 
1/M cells treated with ox-LDL in presence of different concentrations of sage extracts 205 
and standards using ELISA kits (BD biosciences, Spain), according to manufacturer’s 206 
instructions. The color generated was determined by measuring the OD at 450 nm using 207 
a multiscanner autoreader (Sunrise, Tecan).  208 
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 209 
2.8 RNA isolation and RT-PCR 210 
RNA was isolated from THP-1/M cells using Trizol® (Invitrogen, Spain) according to 211 
manufacturer’s instructions. Reverse transcription (RT) of the RNA was performed 212 
using High Capacity Archive Kit and GeneAmp PCR System 9700 (Applied 213 
Biosystems, Carlsbad, CA, USA) according to the manufacturer´s instructions to obtain 214 
20 ng/µL of cDNA. PCR amplification was conducted in a 10 µL reaction mixture with 215 
cDNA, Taqman Gene Expression Master Mix (Applied Biosystems) and TaqMan 216 
probes (Applied Biosystems) according to the manufacturer´s conditions in a 7900HT 217 
Fast Real-Time PCR System (Applied Biosystems). The TaqMan probes used were as 218 
follows: Hs99999029_m1 for IL-1β, Hs00174131_m1 for IL-6, Hs99999035_m1 for 219 
IL-10, Hs00174128_m1 for TNF-α and Hs99999901_s1 for 18S rRNA. Expression of 220 
genes was normalized relative to 18S rRNA using SDS Software v2.4 (Applied 221 
Biosystems).   222 
 223 
2.9 Statistical analysis 224 
All data were expressed as the mean of three determinations ± SD. Data were analyzed 225 
by one-way analysis of variance (ANOVA) followed by Dunnett’s and Bonferroni tests, 226 
using Prism program for Windows (Version 5; GraphPad Software, San Diego, CA, 227 
USA). P values lower than 0.05 were considered significant.  228 
 229 
3. Results  230 
Extraction of sage leaves by using supercritical carbon dioxide was carried out on a 231 
pilot scale plant. Usually, the first step was to determine both, the working pressure and 232 
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temperature, since the optimisation of the experimental conditions represent a critical 233 
step in the development of a SFE process. In this work, the extraction pressure and 234 
temperature were set to 30 MPa and 313 K respectively, using pure CO2 since previous 235 
experiments using extraction pressures of 12, 18 and 35 MPa resulted in extracts with a 236 
lower quantity of essential oils than using 30 MPa (data not shown). These results were 237 
also in agreement with previous studies done in our laboratory with rosemary, oregano 238 
and laurel leaves (García-Risco et al., 2011; Ocaña-Fuentes et al., 2010; Santoyo et al., 239 
2006a; Santoyo et al., 2006b). As already mentioned, the extraction system employed in 240 
the present study allows a cascade of depressurization providing two different extracts: 241 
S1 and S2. The main difference between S1 and S2 extracts was the fractionation 242 
pressure, which brought about a gradual precipitation of the extracted compounds on the 243 
basis of their solubility in the extracting agent at the conditions set in each separator. 244 
These two extracts are expected to present different characteristics in terms of both, 245 
composition and functional activity. Therefore, in this work, the anti-inflammatory 246 
activity of S1 and S2 extracts of sage using an in vitro model of atherosclerosis was 247 
investigated. 248 
 249 
3.1 Effects of supercritical sage extracts on THP-1/M viability  250 
Sage supercritical extracts (S1 and S2) were initially evaluated for cytotoxicity on THP-251 
1/M cells by MTT method. The CC50 data obtained (Table 1) indicated that extract 252 
recovered in separator 2 presented a lower cytotoxicity than extract from separator 1. 253 
However, at the higher concentration used in the (anti-inflammatory) assays, 30 µg/mL, 254 
both extracts (S1 and S2) presented no cytotoxicity. Also S/L extracts at 30 µg/mL, 255 
presented no cytotoxicity. 256 
 257 
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3.2 Effect of sage extracts on the cytokines release 258 
The activation of THP-1/M was carried out with the addition of ox-LDLs to the 259 
medium. These ox-LDLs treated cells showed, after an incubation period of 24h, an 260 
important increase in the release of all pro- and anti-inflammatory cytokines tested 261 
(TNF-α, IL-1β, IL-6 and IL-10) compared to non-activated controls (Figure 1).  These 262 
activated cells were considered as positive controls for all the cytokines tested. When 263 
the activation of THP-1/M was carried out in presence of sage extracts, a decrease in 264 
TNF-α secreted level was observed (Figure 1A), compared with levels obtained in 265 
absence of extracts (positive control). Moreover, a very significant decrease in the 266 
amount of TNF-α secreted was obtained with 30µg/mL of extracts, where TNF-α 267 
secretion was even lower than basal level in non-activated cells. At this concentration, 268 
S1 extract produced a lower TNF-α secretion than S2 extract. Regarding to IL-1β 269 
secretion by activated cells in presence of sage extracts (Figure 1B), it can be also 270 
observed an important decrease in the secretion of this cytokine, with values close to 271 
basal levels presented by non-activated cells. However, in this case, the different 272 
concentrations of sage extracts employed presented a similar decrease in IL-1β release, 273 
indicating that the decrease was not related to the extract concentration. This data could 274 
be explained because the lowest concentration employed in this work (10µg/mL) was 275 
already able to decrease the IL-1β release to basal levels. In this case, S1 extract 276 
induced a lower secretion of IL-1β than S2 extract too. The activation of macrophages 277 
in presence of supercritical extracts also produced a decrease in the IL-6 release (Figure 278 
1C), although an extract concentration higher than 20µg/mL was required. With this 279 
cytokine, S1 and S2 extracts presented a similar activity. Regarding IL-10, an anti-280 
inflammatory cytokine, the presence of extracts did not increase its release. 281 
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These data indicated that supercritical sage extracts presented anti-inflammatory activity 282 
in THP-1 human macrophages activated with human ox-LDL, since these extracts 283 
effectively inhibited the release of pro-inflammatory cytokines as TNF-α, Il-1β and IL-284 
6. 285 
In order to compare the results obtained with supercritical extracts with S/L extracts, 30 286 
µg/mL of these S/L extracts were added to THP-1/M activated with ox-LDLs (data not 287 
included).  Results shown that methanol:chloroform extract decreased the secretion of 288 
TNF-α and IL-6 compared to positive control, meanwhile IL-1 β was not affected. 289 
However, ethanol extract only reduced the secretion of IL-6. When compared these 290 
results with those obtained with supercritical extracts, it can be concluded that S/L 291 
extracts presented a lower decrease of pro-inflammatory cytokines secretion.   292 
  293 
3.3 Effect of supercritical sage extracts on the cytokines mRNA expression 294 
In order to determine if the influence of the supercritical sage extracts in cytokine 295 
production was related to gene expression, total cellular RNA was extracted from 296 
activated THP-1/M and available for RT-PCR. The effect of sage extracts (30µg/mL) on 297 
TNF-α, IL-1β, IL-6 and IL-10 mRNA expression in THP-1/M after 24h of ox-LDLs 298 
activation is presented in Figure 2. TNF-α gene expression was significantly reduced by 299 
both S1 and S2 extracts, compared to the expression of activated cells in absence of the 300 
extracts. Similar results were obtained for IL-1β and IL-6, where extracts significantly 301 
decreased the expression of these interleukins. The decrease in TNF-α, IL-1β and IL-6 302 
gene expression was in agreement with cytokine release indicated before, which 303 
strengthen the anti-inflammatory activity of sage extracts. 304 
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Regarding data obtained with IL-10, sage extracts significantly increase its mRNA 305 
expression, although, as shown previously, these extracts did not increase the release of 306 
IL-10. This result could be explained due to IL-10 presented a slower response to ox-307 
LDL activation than other interleukins tested (Wasaporn et al., 2012). 308 
 309 
3.4 GC-MS characterization of supercritical sage extracts  310 
In an attempt to identify the compounds responsible for the anti-inflammatory activity 311 
found in supercritical sage extracts, a characterization by GC-MS of these samples was 312 
carried out. Results obtained are shown in Table 2, where a tentative identification has 313 
been performed based on the comparison of mass spectra and retention index (RI). As 314 
can be observed, 16 compounds were identified. Some of them were detected in large 315 
amounts like camphor, borneol and 1,8-cineole. The sum of these three compounds 316 
represented a 62.4% of the S1 extract; meanwhile extract obtained on separator 2 317 
contained a smaller quantity (48.1%) of these compounds. In order to correlate the anti-318 
inflammatory activity found in the supercritical extracts with their chemical 319 
composition, the cytotoxicity and anti-inflammatory activity of pure standards of these 320 
three main components of the extracts (camphor, borneol and 1,8-cineole) were also 321 
examined at the same conditions. The cytotoxicity assays revealed that these 322 
compounds were more cytotoxic than supercritical extracts, specially 1,8-cineole and 323 
borneol (Table 1). The concentrations used to carry out the experiments (7.5 and 5 324 
µg/mL) presented 100% cell viability in all cases.  325 
When the activation of THP-1/M was carried out in presence of camphor, borneol and 326 
1,8-cineole, an important decrease in TNF-α secreted level was observed, especially 327 
when employing 7.5 µg/mL (Figure 1A). At this concentration, borneol and 1,8-cineole 328 
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were more active than camphor, since they produced a lower TNF-α secretion. Figure 329 
1B also showed an important decrease in the secretion of IL-1β, with values close to 330 
basal levels, with 7.5 µg/mL of camphor, 1,8-cineole and borneol. In this case, no 331 
differences were found among the three compounds. The IL-6 release (Figure 1C), also 332 
presented a great decrease in presence of camphor, 1,8-cineole and borneol. These data 333 
indicated that the three compounds presented an important anti-inflammatory activity. 334 
However, camphor, 1,8-cineole and borneol did not increase the release of the anti-335 
inflammatory cytokine IL-10 (Figure 1D) at the concentrations used.  336 
Also, formulation of model mixtures with pure standards, mimicking the composition of 337 
the S1 and S2 extracts based on the compositions of Table 2, were carried out. When 338 
the activation of THP-1/M was studied in presence of these mixtures, at 30 µg/mL, an 339 
important decrease in all cytokines studied was found (Figure 1). When these results 340 
were compared with those obtained with supercritical extracts, no significant 341 
differences were found.  342 
The effect of camphor, 1,8-cineole and borneol (7.5µg/mL) on TNF-α, IL-1β, IL-6 and 343 
IL-10 mRNA expression in THP-1/M after 24h of ox-LDLs activation was also studied 344 
(Figure 2). TNF-α, IL-1β and IL-6 gene expression was significantly reduced by the 345 
three compounds tested. Regarding IL-10 gene transcription, an important increase was 346 
observed when activation was carried out in presence of camphor, borneol and 1,8-347 
cineole. Surprisingly, this important increase in IL-10 gene expression was not related 348 
with data obtained in the secretion of these IL-10 measured by ELISA. This result, 349 
found also for sage extracts, could be related with the time of the treatment, since a 24h 350 
treatment could be able to increase the gene expression but not the release of this 351 
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cytokine to medium, due to IL-10 presented a slower response to ox-LDL stimulation 352 
than other cytokines. 353 
Thus, these compounds presented an important anti-inflammatory activity in the 354 
proposed model, with a decrease in the release and gene expression of pro-inflammatory 355 
cytokines and an increase in gene expression of IL-10, an anti-inflammatory cytokine. 356 
However, data did not show important differences among the activity of the three 357 
compounds. Accordingly borneol, camphor and 1,8-cineole could be proposed as the 358 
principal compounds responsible for the anti-inflammatory activity found in 359 
supercritical sage S1 and S2 extracts. Data also explained the higher activity found in 360 
extract obtained in S1, since this fraction contained a higher quantity of borneol, 361 
camphor and 1,8-cineole than extract S2). TNF-α, IL-1β and IL-6 gene expression using 362 
model mixtures of pure standards did not presented significant differences compare with 363 
results obtained when using supercritical extracts (data not shown). 364 
 365 
4. Discussion 366 
Low-density lipoprotein oxidation appears to be a fundamental event in the 367 
development of the atherosclerotic lesion and the initiation of the inflammatory cascade 368 
(Call et al., 2004). Ox-LDL can induce the expression of pro-inflammatory cytokines, 369 
such as IL-1β, TNF-α and IL-6 from monocytes and macrophages. IL-1β and TNF-α are 370 
primary pro-inflammatory cytokines, which are mainly produced by monocytes and 371 
macrophages, and play a crucial role in the initial amplification of the inflammatory 372 
response. In vivo and in vitro research has highlighted their potential pro-atherogenic 373 
action. In particular, it has been shown that both IL-1β and TNF-α could induce the 374 
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expression of adhesion molecules by endothelial cells, promote secretion of different 375 
cytokines and chemokines by monocytes, and may enhance the smooth muscle cells 376 
proliferation and migration (Rattazzi et al., 2004). They can also actively participate in 377 
the process of foam cell formation mainly through the induction of grown factors. These 378 
cytokines also play a crucial role in the later stage of atheroma development by 379 
hampering plaque stability (Young et al., 2002). IL-6 is a secondary inflammatory 380 
cytokine produced by different kinds of cellular elements such as activated 381 
macrophages, lymphocytes, fibroblast, and vascular smooth muscle cells under 382 
stimulation by IL-1 and TNF-α. IL-6 may exert an important direct pathogenic role in 383 
atherosclerosis development and progression, especially through inflammatory elements 384 
recruitment and smooth muscle cells activation (Rattazzi et al., 2004). 385 
The aim of this study was to investigate the anti-inflammatory capacity of supercritical 386 
Salvia officinalis extracts using THP-1 human macrophages activated with human ox-387 
LDL, since this model of inflammation allowed us to determine the anti-inflammatory 388 
effect of the extracts in an atherosclerotic environment and could be useful to determine 389 
the potential activity of the extracts in the prevention of atherosclerosis. The results 390 
suggested that supercritical sage S1 and S2 fractions may act as effective inhibitors of 391 
ox-LDL induced pro-inflammatory cytokines (TNF-α, IL-1β and IL-6). Moreover, a 392 
very significant decrease in the secretion of these cytokines was obtained with 30 393 
μg/mL of sage extracts, since pro-inflammatory cytokines secretion levels with this 394 
concentration were even lower than its basal level in non activated cells. These results 395 
were also in agreement with the ones obtained regarding the transcription of cytokines 396 
genes at 24 h of incubation. In that way, Mueller et al. (2010), also reported that an 397 
extract from sage leaves was able to reduce the secretion of pro-inflammatory cytokines 398 
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TNF-α and IL-6 in a lipopolysaccharide-stimulated macrophage model, although the 399 
extract concentrations employed in this study were 0.2-0.5 mg/mL. Other authors also 400 
reported the anti-inflammatory activity of sage extracts, although the anti-inflammatory 401 
activity was evaluated using the 5-lipoxigenase enzyme (Kamatou et al., 2010). The 402 
IC50 values reported for sage extracts against 5-lipoxygenase enzyme were greater than 403 
100µg/mL, with the exception of Salvia radula (IC50 value: 78.8µg/mL). Besides, a 404 
Salvia miltiorrhiza extract also suppressed LPS-induced TNF-α in human peripheral 405 
leukocytes and the Raw 264.7 macrophage cell line (Wang et al., 2006). Therefore, it is 406 
likely that small doses of supercritical sage extracts (30 μg/mL) inhibit ox-LDL induced 407 
TNF-α, IL-1β and IL-6 production by THP-1 human macrophages preventing cytokine 408 
stimulation, which may contribute to the anti-inflammatory effect in atherosclerotic 409 
condition. 410 
IL-10 is an anti-inflammatory cytokine that inhibits the production of IL-2 and INF-γ by 411 
Th1 cells, reduces pro-inflammatory cytokines production and down-regulated 412 
eosinophil function and activity (Konno et al., 2006). Results obtained in this work 413 
indicated that sage supercritical extracts significantly increase IL-10 mRNA expression 414 
by the activated macrophages, although these extracts did not produce a significant 415 
increased in IL-10 release at 24h of stimulation. According to these data, Chen et al. 416 
(2011), reported that Salvianolic acid B, a compound isolated from dry root of Salvia 417 
miltiorrhiza enhanced the expresion of IL-10. 418 
Main compounds presented in supercritical sage extracts were camphor, borneol and 419 
1,8-cineole. These compounds represented a 62.4% in S1 extract and a 48.1% in S2 420 
extract. These results indicated that the fractionation step increased the oxygenated 421 
monoterpenes composition in the extract obtained in the first separator. Similar results 422 
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were reported by Fornari et al. (2012) using a similar procedure. Gañán and Brignole 423 
(2013) also showed that a SFE fractionation of S. officinalis essential oil enriched sage 424 
extract in oxygenated monoterpenes, being 1,8-cineol, α-thujone, β-thujone and 425 
camphor the main compounds.  426 
A concentration of 7.5 μg/mL of 1,8-cineol, camphor and borneol showed an important 427 
decrease in both soluble levels and gene expression of TNF-α, IL-1β and IL-6 by 428 
stimulated THP1/M. IL-10 gene expression at 24h was also up-regulated by the 429 
presence of 7.5 μg/mL camphor, borneol and 1,8-cineole. The anti-inflammatory 430 
activity showed by these components was in agreement with the results showed by 431 
Juergens et al. (2004), who reported 1,8-cineole as a strong inhibitor of TNF-α, IL-1β 432 
and IL-6 production by human unselected lymphocytes and LPS-stimulated monocytes. 433 
Santos and Rao (2000), also reported the inhibitory effect of 1,8-cineole, a terpenoid 434 
oxide present in many plant essential oils, on the pro-inflammatory cytokines 435 
production by stimulated monocytes. Regarding borneol, Tung et al. (2008), indicated 436 
that this compound exhibited excellent anti-inflammatory activity in suppressing nitric 437 
oxide production by LPS-stimulated macrophages. In addition, camphor has been also 438 
reported to have significant anti-inflammatory activity (Yoon et al., 2010; Chainy et al., 439 
2000). The mixtures prepared with camphor, 1,8-cineol and borneol in order to simulate 440 
the composition of extract S1 and S2 have showed a similar anti-inflammatory effect 441 
than the supercritical extracts. These results were expected since these pure standards 442 
represented a 62.4% of the S1 extract and a 48.1% of S2 and these compounds, when 443 
using individually, have demonstrated a potent anti-inflammatory activity. 444 
Concluding, supercritical fluid extraction allowed the production of sage extracts with 445 
an important anti-inflammatory activity using an atherosclerotic environment model. 446 
20 
 
These extracts act as effective inhibitors of ox-LDL induced pro-inflammatory 447 
cytokines (TNF-α, IL-1β and IL-6) and therefore have a great potential to be used as 448 
anti-inflammatory agents in the prevention of atherosclerosis. 449 
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Table 1.  THP-1/M cell viability in presence of supercritical sage extracts and pure 579 
standards. CC50 (cytotoxic concentration 50%): concentration required to reduce 50% 580 
the number of viable THP-1/M cells after 24 h of incubation with the compounds. a,b,c,d 581 
Different superscript letters indicated significant differences (p<0.05) among data. 582 
Sample CC50 (μg/mL) 
Sage S1 66.70 ± 5.41 a 
Sage S2 80.24 ± 7.58 b 
Camphor 55.75 ± 6.12 c 
1,8-Cineole 35.32 ± 4.21 d 
Borneol 26.93 ± 2.78 d 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
 591 
 592 
 593 
 594 
 595 
 596 
 597 
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Table 2. GC-MS identification, peak area contribution (normalized area percent), and 598 
retention index (RI) of compounds found in supercritical extracts (S1 and S2) from sage 599 
(Salvia officinalis). NI: non-identified compound, n.d.: non detected. 600 
 601 
Retention time 
(min) 
RI Compound 
S1 
normalized 
area (%) 
S2 
normalized 
area (%)  
13.33 1029 1,8-Cineole 13.34 4.64 
17.38 1099 Linalool 1.16 1.10 
19.64 1138 Cis-sabinol 2.05 n.d. 
19.78 1140 Camphor 41.78 33.9 
21.07 1163 Borneol 7.28 9.56 
22.55 1188 Alpha-terpineol 1.16 1.81 
26.44 1253 Linalyl acetate 4.86 5.81 
28.19 1282 Endobornyl acetate 3.19 3.46 
28.70 1291 Sabinyl acetate 5.00 5.94 
32.60 1345 α-terpinenyl 3.68 4.71 
37.84 1412 E-cariophyllene 2.33 2.97 
40.65 1484 α-humulene 1.75 2.41 
43.05 1535 Geranyl propionate 1.25 1.91 
51.19 1575 Spathulenol 1.01 2.05 
51.48 1579 Cariophyllene oxide 1.03 1.61 
52.04 1586 viridiflorol 2.00 4.02 
56.61 1685 NI 2.11 5.06 
 602 
 603 
 604 
 605 
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Figure legends 606 
Figure 1: Levels of TNF-α (1A), IL-1β (1B), IL-6 (1C) and IL-10 (1D) secreted by 607 
THP-1/M activated with ox-LDL in presence of supercritical sage extracts, pure 608 
standards or mixtures of pure standards simulate sage S1 and S2 extracts. Each bar is 609 
the mean of three determinations  standard deviation. * Denotes statistical differences 610 
between control+ox-LDL and the other samples at p<0.05. a,b Columns with different 611 
superscript letters are significantly different at p<0.05 (comparison between S1 and S2 612 
sage extracts and mixtures of pure standards at 30 μg/mL).613 
 614 
Figure 2: mRNA expression of TNF-α (2A), IL-1β (2B), IL-6 (2C) and IL-10 (2D) on 615 
THP-1/M stimulated with ox-LDL in presence of supercritical sage extracts or pure 616 
standards. Each bar is the mean of three determinations  standard deviation. RQ: 617 
relative quantification. * Denotes statistical differences between control+ox-LDL and 618 
the other samples at p<0.05. 619 
 620 
 621 
 622 
 623 
 624 
 625 
 626 
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